Chemical Engineering / Kimya Mühendisliği

Permanent URI for this collectionhttps://hdl.handle.net/11147/14

Browse

Search Results

Now showing 1 - 2 of 2
  • Article
    Citation - WoS: 20
    Citation - Scopus: 26
    Pops in a Major Conurbation in Turkey: Ambient Air Concentrations, Seasonal Variation, Inhalation and Dermal Exposure, and Associated Carcinogenic Risks
    (Springer Verlag, 2016) Ugranlı, Tuğba; Güngörmüş, Elif; Kavcar, Pınar; Demircioğlu, Eylem; Odabaşı, Mustafa; Sofuoğlu, Sait Cemil; Lammel, Gerhard; Sofuoglu, Aysun
    Semi-volatile organic compounds were monitored over a whole year, by collection of gas and particle phases every sixth day at a suburban site in Izmir, Turkey. Annual mean concentrations of 32 polychlorinated biphenyls (∑32PCBs) and 14 polycyclic aromatic hydrocarbons (∑14PAHs) were 348 pg/m3 and 36 ng/m3, respectively, while it was 273 pg/m3 for endosulfan, the dominant compound among 23 organochlorine pesticides (OCPs). Monte Carlo simulation was applied to the USEPA exposure-risk models for the estimation of the population exposure and carcinogenic risk probability distributions for heating and non-heating periods. The estimated population risks associated with dermal contact and inhalation routes to ∑32PCBs, ∑14PAHs, and some of the targeted OCPs (α-hexachlorocyclohexane (α-HCH), β-hexachlorocyclohexane (β-HCH), heptachlor, heptachlor epoxide, α-chlordane (α-CHL), γ-chlordane (γ-CHL), and p,p′-dichlorodiphenyltrichloroethane (p,p′-DDT)) were in the ranges of 1.86 × 10−16–7.29 × 10−9 and 1.38 × 10−10–4.07 × 10−6, respectively. The inhalation 95th percentile risks for ∑32PCBs, ∑14PAHs, and OCPs were about 6, 3, and 4–7 orders of magnitude higher than those of dermal route, respectively. The 95th percentile inhalation risk for ∑32PCBs and OCPs in the non-heating period were 1.8- and 1.2–4.6 folds higher than in the heating period, respectively. In contrast, the 95th percentile risk levels for ∑14PAHs in the heating period were 4.3 times greater than that of non-heating period for inhalation, respectively. While risk levels associated with exposure to PCBs and OCPs did not exceed the acceptable level of 1 × 10−6, it was exceeded for 47 % of the population associated with inhalation of PAHs with a maximum value of about 4 × 10−6.
  • Article
    Citation - WoS: 37
    Citation - Scopus: 39
    Inhalation and Dermal Exposure To Atmospheric Polycyclic Aromatic Hydrocarbons and Associated Carcinogenic Risks in a Relatively Small City
    (Elsevier Ltd., 2014) Güngörmüş, Elif; Tuncel, Semra; Tecer, Lokman Hakan; Sofuoğlu, Sait Cemil
    The aim of this study was to conduct a carcinogenic risk assessment for exposure to polycyclic aromatic hydrocarbons (PAHs) via routes of inhalation and dermal contact. Concentrations of 19 PAH species were determined during a heating period at a site in the city of Balikesir, Turkey. Two questionnaires were administered to a sample of inhabitants to determine time-activity budgets and demographic information. The assessment was conducted for each participant and Balikesir population by deterministic and probabilistic approaches, respectively. Monte Carlo simulation was implemented to determine the population exposure-risk probability distributions. The estimates were based on benzo[a]pyrene equivalent (BaPeq) total PAH concentrations calculated using toxic equivalency factors. The mean and median BaPeq concentrations of gaseous and particulate phases were 3.25 and 1.34, and 38.5 and 34.0ng/m3, respectively. Carcinogenic risk for inhalation exposure route was estimated by using two different slope factor values (3.9 and 304.5(mg/kg-day)-1), recommended by two different organizations, resulting in two (order(s) of magnitude apart) population risk ranges: 1.32×10-7-2.23×10-4, and 1.61×10-5-7.95×10-3, respectively. The population risks associated with dermal exposure were lower compared to those of inhalation, ranging from 6.58×10-9 to 2.57×10-6. The proportion of the population with risks higher than the general acceptable level (1.0×10-6) was estimated as >99 percent, for inhalation, and as 28 percent for dermal exposure route.